Skip to main content
. 2020 Sep 19;35(1):e23569. doi: 10.1002/jcla.23569

Table 1.

Clinical data and laboratory tests

Item RA group Other rheumatic diseases group Control group
Number 1009 170 245
Age, years (mean ± SD, range) 64.52 ± 10.12 68.26 ± 8.15 61.45 ± 12.50
Gender (F/M) 191/818 32/138 48/197
RF (IU/mL) 129.00 (41.85‐394.00) a , b 59.52 (21.90‐136.50) b 8.00 (4.40‐14.30)
CRP (mg/L) 13.55 (10.37‐50.93) a , b 8.16 (4.15‐29.87) b 2.30 (1.50‐3.01)
ESR (mm/H) 50.50 (28.25‐79.00) b 33.5 (17‐61.75) b 24.00 (17.00‐31.00)
NEUT (×109) 4.65 (3.35‐6.36) a , b 4.28 (3.11‐5.05) b 3.50 (2.71‐4.25)
Ly (×109) 1.41 (1.07‐1.91) a , b 1.64 (1.23‐2.10) b 2.17 (1.76‐2.70)
PLT 244 (192‐312) 224 (188‐266) 255 (215‐296)
NLR 3.23 (2.14‐4.80) a , b 2.36 (1.78‐3.63) b 1.54 (1.24‐2.05)
PLR 168.68 (124.45‐239.57) a , b 130.73 (95.83‐174.15) b 113.77 (92.97‐144.95)

Abbreviations: CRP, C‐reactive protein; ESR, erythrocyte sedimentation rate; Ly, lymphocyte; NEUT, neutrophil; NLR, neutrophil‐to‐lymphocyte ratio; PLR, platelet‐to‐lymphocyte ratio; PLT, platelet; RF, rheumatoid factor.

a

P < .05 vs rheumatic diseases group.

b

P < .05 vs control group.